Evidence map›Paper›PMID 25330249›Full record

ArticlePLoS neglected tropical diseases2014

Early double-negative thymocyte export in Trypanosoma cruzi infection is restricted by sphingosine receptors and associated with human chagas disease.

Ailin Lepletier, Liliane de Almeida, Leonardo Santos, Luzia da Silva Sampaio, Bruno Paredes, Florencia Belén González, Célio Geraldo Freire-de-Lima, Juan Beloscar, Oscar Bottasso, Marcelo Einicker-Lamas and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Infection-Associated Thymic Atrophy.Frontiers in immunology · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Immune Evasion Strategies of Trypanosoma cruzi.Journal of immunology research · 2015
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Ailin LepletierLaboratory on Thymus Research, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Liliane de AlmeidaInstitute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Leonardo SantosInstitute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Luzia da Silva SampaioCarlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Bruno ParedesCarlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Florencia Belén GonzálezInstitute of Immunology, National University of Rosario, Rosario, Argentina.
Célio Geraldo Freire-de-LimaCarlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Juan BeloscarServicio de Clínica Médica, Hospital J.B. Iturraspe, Santa Fe, Argentina.
Oscar BottassoServicio de Clínica Médica, Hospital J.B. Iturraspe, Santa Fe, Argentina.
Marcelo Einicker-LamasCarlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Ana Rosa PérezInstitute of Immunology, National University of Rosario, Rosario, Argentina.
Wilson SavinoLaboratory on Thymus Research, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Alexandre MorrotInstitute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro · BRFundação Oswaldo Cruz · BRNational University of Rosario · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protozoan parasite Trypanosoma cruzi is able to target the thymus and induce alterations of the thymic microenvironmental and lymphoid compartments. Acute infection results in severe atrophy of the organ and early release of immature thymocytes into the periphery. To date, the pathophysiological effects of thymic changes promoted by parasite-inducing premature release of thymocytes to the periphery has remained elusive. Herein, we show that sphingosine-1-phosphate (S1P), a potent mediator of T cell chemotaxis, plays a role in the exit of immature double-negative thymocytes in experimental Chagas disease. In thymuses from T. cruzi-infected mice we detected reduced transcription of the S1P kinase 1 and 2 genes related to S1P biosynthesis, together with increased transcription of the SGPL1 sphingosine-1-lyase gene, whose product inactivates S1P. These changes were associated with reduced intrathymic levels of S1P kinase activity. Interestingly, double-negative thymocytes from infected animals expressed high levels of the S1P receptor during infection, and migrated to lower levels of S1P. Moreover, during T. cruzi infection, this thymocyte subset expresses high levels of IL-17 and TNF-α cytokines upon polyclonal stimulation. In vivo treatment with the S1P receptor antagonist FTY720 resulted in recovery the numbers of double-negative thymocytes in infected thymuses to physiological levels. Finally, we showed increased numbers of double-negative T cells in the peripheral blood in severe cardiac forms of human Chagas disease.

Indexed as

Trypanosoma cruziAnimalsCase-Control StudiesChagas DiseaseHumansLeukocytes, MononuclearLysophospholipidsMaleMiceMice, Inbred BALB CReceptors, LysosphingolipidRNA, MessengerSphingosineSphingosine-1-Phosphate ReceptorsThymocytesT-LymphocytesLysophospholipidsReceptors, LysosphingolipidRNA, MessengerS1PR1 protein, humanS1pr1 protein, mouseS1pr3 protein, mouseSphingosinesphingosine 1-phosphateSphingosine-1-Phosphate Receptors

Identifiers

PMID25330249
PMCPMC4199546
OpenAlexW2089866373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.